125 related articles for article (PubMed ID: 23653936)
1. [Cholagenic diarrhea is a type of postcholescystectomy syndrome].
Krums LM; Parfenov AI; Gubina AV; Sil'vestrova SIu; Smirnova AV
Ter Arkh; 2013; 85(2):32-5. PubMed ID: 23653936
[TBL] [Abstract][Full Text] [Related]
2. [The role of bile acids in the pathogenesis of chronic diarrhea].
Krums LM; Gubina AV; Parfenov AI; Sil'vestrova SIu
Eksp Klin Gastroenterol; 2012; (3):35-9. PubMed ID: 22830222
[TBL] [Abstract][Full Text] [Related]
3. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.
Duboc H; Rainteau D; Rajca S; Humbert L; Farabos D; Maubert M; Grondin V; Jouet P; Bouhassira D; Seksik P; Sokol H; Coffin B; Sabaté JM
Neurogastroenterol Motil; 2012 Jun; 24(6):513-20, e246-7. PubMed ID: 22356587
[TBL] [Abstract][Full Text] [Related]
4. Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome-Diarrhea Without Bile Acid Malabsorption.
Peleman C; Camilleri M; Busciglio I; Burton D; Donato L; Zinsmeister AR
Clin Gastroenterol Hepatol; 2017 May; 15(5):720-727.e1. PubMed ID: 27856362
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome.
Róka R; Rosztóczy A; Leveque M; Izbéki F; Nagy F; Molnár T; Lonovics J; Garcia-Villar R; Fioramonti J; Wittmann T; Bueno L
Clin Gastroenterol Hepatol; 2007 May; 5(5):550-5. PubMed ID: 17336590
[TBL] [Abstract][Full Text] [Related]
6. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
7. Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea.
Camilleri M; Busciglio I; Acosta A; Shin A; Carlson P; Burton D; Ryks M; Rhoten D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
Am J Gastroenterol; 2014 Oct; 109(10):1621-30. PubMed ID: 25070056
[TBL] [Abstract][Full Text] [Related]
8. [The use of bismuth tripotassium dicitrate (De-Nol), a promising line of pathogenetic therapy for irritated bowel syndrome with diarrhea].
Iakovenko EP; Agafonova NA; Pokhal'skaia OIu; Kolganova AV; Nazarbekova RS; Ivanov AN; Davletshina IV; Popova EV; Prianishnikova AS; Ovchinnikova NI; Iakovenko AV; Aldiiarova MA; D'iachkoava AV; Gioeva IZ
Klin Med (Mosk); 2008; 86(10):47-52. PubMed ID: 19069460
[TBL] [Abstract][Full Text] [Related]
9. Bile acid malabsorption: an under-investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms.
Kurien M; Evans KE; Leeds JS; Hopper AD; Harris A; Sanders DS
Scand J Gastroenterol; 2011 Jul; 46(7-8):818-22. PubMed ID: 21492055
[TBL] [Abstract][Full Text] [Related]
10. AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
Carrasco-Labra A; Lytvyn L; Falck-Ytter Y; Surawicz CM; Chey WD
Gastroenterology; 2019 Sep; 157(3):859-880. PubMed ID: 31351880
[TBL] [Abstract][Full Text] [Related]
11. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
[TBL] [Abstract][Full Text] [Related]
12. Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis.
Gecse K; Róka R; Séra T; Rosztóczy A; Annaházi A; Izbéki F; Nagy F; Molnár T; Szepes Z; Pávics L; Bueno L; Wittmann T
Digestion; 2012; 85(1):40-6. PubMed ID: 22179430
[TBL] [Abstract][Full Text] [Related]
13. [Cholagenic diarrhea].
Parfenov AI; Krums LM; Lychkova AE; Poleva NI
Ter Arkh; 2008; 80(2):33-8. PubMed ID: 18372593
[TBL] [Abstract][Full Text] [Related]
14. Validating biomarkers of treatable mechanisms in irritable bowel syndrome.
Camilleri M; Shin A; Busciglio I; Carlson P; Acosta A; Bharucha AE; Burton D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
Neurogastroenterol Motil; 2014 Dec; 26(12):1677-85. PubMed ID: 25244349
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Fecal Primary Bile Acids Detects Increased Stool Weight and Colonic Transit in Patients With Chronic Functional Diarrhea.
Vijayvargiya P; Camilleri M; Chedid V; Carlson P; Busciglio I; Burton D; Donato LJ
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):922-929.e2. PubMed ID: 29902647
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.
Lee KJ; Kim NY; Kwon JK; Huh KC; Lee OY; Lee JS; Choi SC; Sohn CI; Myung SJ; Park HJ; Choi MK; Bak YT; Rhee PL
Neurogastroenterol Motil; 2011 Dec; 23(12):1098-104. PubMed ID: 21920001
[TBL] [Abstract][Full Text] [Related]
17. [Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome].
Moskwa A; Chojnacki J; Wiśiewska-Jarosińska M; Stec-Michalska K; Szadkowski K; Smigielski J; Chojnacki C
Pol Merkur Lekarski; 2007 May; 22(131):366-8. PubMed ID: 17679369
[TBL] [Abstract][Full Text] [Related]
18. Spotlight: Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
Smalley W; Falck-Ytter C; Carrasco-Labra A; Wani S; Lytvyn L; Falck-Ytter Y
Gastroenterology; 2019 Sep; 157(3):858. PubMed ID: 31377275
[No Abstract] [Full Text] [Related]
19. Fecal Bile Acid Testing in Assessing Patients With Chronic Unexplained Diarrhea: Implications for Healthcare Utilization.
Vijayvargiya P; Gonzalez Izundegui D; Calderon G; Tawfic S; Batbold S; Camilleri M
Am J Gastroenterol; 2020 Jul; 115(7):1094-1102. PubMed ID: 32618660
[TBL] [Abstract][Full Text] [Related]
20. AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
Smalley W; Falck-Ytter C; Carrasco-Labra A; Wani S; Lytvyn L; Falck-Ytter Y
Gastroenterology; 2019 Sep; 157(3):851-854. PubMed ID: 31302098
[No Abstract] [Full Text] [Related]
[Next] [New Search]
